source
- FDA reviewers recommend against adding seven peptides to bulk drug list for compoundingFDA reviewers have advised that seven widely used peptides should not be added to the FDA's bulk drug substance list for compounding. Their recommendation comes before an upcoming advisory committe…
- Abivax reports ulcerative colitis trial cancer rates align with expectationsAbivax released new data from its Phase 3 trial of an ulcerative colitis candidate. The data show that the number of cancer cases observed was within the range normally expected for ulcerative col…